Home/ Stocks/ ELUT

Elutia Inc. Class A Common Stock

ELUT XNAS

$1.01 +0.01 (+1.12%) ▲ 15-min delayed

Open

$1.05

High

$1.05

Low

$0.99

Volume

129.5K

Market Cap

$47.03M

About Elutia Inc. Class A Common Stock

Elutia Inc develops proprietary drug-eluting biomatrix products for use in surgical reconstruction and related applications. These products are designed to improve the interaction between implanted medical devices and patients. Its products include CanGaroo, designed for implantable electronic devices, and SimpliDerm, used in soft tissue repair, with functions related to implant support and wound management. The company operates in two segments: Women's Health and Cardiovascular. The majority of revenue is derived from the Women's Health segment.

Sector: BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) Employees: 26 Website →

Key Financials

Period	Revenue	Net Income	EPS
TTM 2025	$12.29M	$53.38M	$1.29
FY 2025	$12.29M	$53.38M	$1.29
Q3 2025	$3.32M	$-3,868,000	$-0.09
Q2 2025	$6.26M	$-9,610,000	$-0.23

Related Market News

No specific coverage for ELUT yet. Check out our latest market news or earnings calendar.

Get ELUT Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Elutia Inc. Class A Common Stock.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.